Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Thomas Marjot and A Barritt.
Connection Strength

1.708
  1. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021 05; 18(5):348-364.
    View in: PubMed
    Score: 0.233
  2. Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. J Hepatol. 2021 07; 75(1):226-228.
    View in: PubMed
    Score: 0.232
  3. SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol. 2021 06; 74(6):1335-1343.
    View in: PubMed
    Score: 0.232
  4. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021 03; 6(3):156-158.
    View in: PubMed
    Score: 0.231
  5. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021 03; 74(3):567-577.
    View in: PubMed
    Score: 0.227
  6. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary resultsĀ from an international registry. J Hepatol. 2020 09; 73(3):705-708.
    View in: PubMed
    Score: 0.221
  7. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol. 2020 07; 5(7):643-644.
    View in: PubMed
    Score: 0.220
  8. COVID-19 and liver transplantation: the jury is still out - Authors' reply. Lancet Gastroenterol Hepatol. 2021 01; 6(1):11.
    View in: PubMed
    Score: 0.057
  9. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol. 2020 11; 5(11):1008-1016.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.